Access Bio, Inc. (KOSDAQ:950130)

Access Bio Statistics

Total Valuation

Access Bio has a market cap or net worth of KRW 185.01 billion. The enterprise value is -163.29 billion.

Market Cap	185.01B
Enterprise Value	-163.29B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Access Bio has 35.17 million shares outstanding. The number of shares has decreased by -1.45% in one year.

Current Share Class	n/a
Shares Outstanding	35.17M
Shares Change (YoY)	-1.45%
Shares Change (QoQ)	+2.14%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.28%
Float	26.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.49
PB Ratio	0.31
P/TBV Ratio	0.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	7.55
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	8.21

Financial Position

The company has a current ratio of 15.67, with a Debt / Equity ratio of 0.10.

Current Ratio	15.67
Quick Ratio	14.55
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-2.98
Interest Coverage	-11.75

Financial Efficiency

Return on equity (ROE) is -3.69% and return on invested capital (ROIC) is -3.44%.

Return on Equity (ROE)	-3.69%
Return on Assets (ROA)	-3.36%
Return on Invested Capital (ROIC)	-3.44%
Return on Capital Employed (ROCE)	-5.85%
Revenue Per Employee	736.85M
Profits Per Employee	-214.26M
Employee Count	101
Asset Turnover	0.11
Inventory Turnover	2.50

Taxes

Income Tax	-6.19B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.40% in the last 52 weeks. The beta is 0.24, so Access Bio's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	-39.40%
50-Day Moving Average	5,414.40
200-Day Moving Average	5,413.85
Relative Strength Index (RSI)	47.28
Average Volume (20 Days)	166,306

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Access Bio had revenue of KRW 74.42 billion and -21.64 billion in losses. Loss per share was -634.90.

Revenue	74.42B
Gross Profit	15.99B
Operating Income	-37.34B
Pretax Income	-28.78B
Net Income	-21.64B
EBITDA	-17.55B
EBIT	-37.34B
Loss Per Share	-634.90

Balance Sheet

The company has 409.26 billion in cash and 59.20 billion in debt, giving a net cash position of 350.06 billion or 9,952.28 per share.

Cash & Cash Equivalents	409.26B
Total Debt	59.20B
Net Cash	350.06B
Net Cash Per Share	9,952.28
Equity (Book Value)	599.93B
Book Value Per Share	17,006.26
Working Capital	415.34B

Cash Flow

In the last 12 months, operating cash flow was -18.65 billion and capital expenditures -1.23 billion, giving a free cash flow of -19.88 billion.

Operating Cash Flow	-18.65B
Capital Expenditures	-1.23B
Free Cash Flow	-19.88B
FCF Per Share	-565.24

Margins

Gross margin is 21.48%, with operating and profit margins of -50.17% and -29.08%.

Gross Margin	21.48%
Operating Margin	-50.17%
Pretax Margin	-38.67%
Profit Margin	-29.08%
EBITDA Margin	-23.58%
EBIT Margin	-50.17%
FCF Margin	n/a

Dividends & Yields

Access Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.45%
Shareholder Yield	n/a
Earnings Yield	-11.70%
FCF Yield	-10.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Access Bio has an Altman Z-Score of 3.73 and a Piotroski F-Score of 3.

Altman Z-Score	3.73
Piotroski F-Score	3